John R. Cirrito

Active 2000–2026

70
Papers
20,265
Citations
55
h-index
67
i10-index

Citations

Citations per year for John R. Cirrito2000: 1 citations2001: 6 citations2002: 18 citations2003: 11 citations2004: 35 citations2005: 52 citations2006: 63 citations2007: 74 citations2008: 108 citations2009: 152 citations2010: 173 citations2011: 213 citations2012: 275 citations2013: 331 citations2014: 426 citations2015: 435 citations2016: 428 citations2017: 517 citations2018: 448 citations2019: 1,015 citations2020: 1,143 citations2021: 1,050 citations2022: 865 citations2023: 800 citations2024: 953 citations2025: 500 citations2026: 18 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,643 citing papers, 32.3% of this breakdownChina: 1,120 citing papers, 9.9% of this breakdownUnited Kingdom: 760 citing papers, 6.7% of this breakdownGermany: 616 citing papers, 5.5% of this breakdownCanada: 413 citing papers, 3.7% of this breakdownItaly: 376 citing papers, 3.3% of this breakdownFrance: 339 citing papers, 3% of this breakdownJapan: 323 citing papers, 2.9% of this breakdownSpain: 322 citing papers, 2.9% of this breakdownAustralia: 319 citing papers, 2.8% of this breakdownSweden: 289 citing papers, 2.6% of this breakdownNetherlands: 236 citing papers, 2.1% of this breakdown
0%32.3%Other 22.3%

Fields

  • Medicine48.5%
  • Neuroscience33.2%
  • Biochemistry, Genetics and Molecular Biology11.1%
  • Psychology2.7%
  • Immunology and Microbiology2.1%
  • Computer Science0.5%
  • Other1.9%

Topics

  • Alzheimer's disease research and treatments17.2%
  • Neuroinflammation and Neurodegeneration Mechanisms9.1%
  • Neuroscience and Neuropharmacology Research3.9%
  • Dementia and Cognitive Impairment Research3.1%
  • Cholinesterase and Neurodegenerative Diseases3%
  • Sleep and Wakefulness Research2.5%
  • Other61.2%

Coauthors

All papers

Open in search
  1. TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model

    Authors: , , , , , , , , , , , , - Cell 2015 cited by 1,826

  2. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans

    Authors: , , , , , , , , , , , - Science 2019 cited by 816

  3. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2016 cited by 882

  4. Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle

    Authors: , , , , , , , , - Science 2009 cited by 1,574

  5. Neuronal activity regulates extracellular tau in vivo

    Authors: , , , , , , , , , , - The Journal of Experimental Medicine 2014 cited by 602

  6. Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo

    Authors: , , , , , , , , , - Neuron 2005 cited by 1,273

  7. Neuronal activity regulates the regional vulnerability to amyloid-β deposition

    Authors: , , , , , , , - Nature Neuroscience 2011 cited by 890

  8. Neuronal Clearance of Amyloid-β by Endocytic Receptor LRP1

    Authors: , , , , , , , , - Journal of Neuroscience 2013 cited by 279

  9. Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 359

  10. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition

    Authors: , , , , , , , , - Journal of Neuroscience 2017 cited by 261

  11. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 647

  12. Enhancing Astrocytic Lysosome Biogenesis Facilitates Aβ Clearance and Attenuates Amyloid Plaque Pathogenesis

    Authors: , , , , , , , , , , , - Journal of Neuroscience 2014 cited by 266

  13. ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

    Authors: , , , , , , , , , , , , - Science 2012 cited by 1,042

  14. Antisense Reduction of Tau in Adult Mice Protects against Seizures

    Authors: , , , , , , , , , , , , , - Journal of Neuroscience 2013 cited by 312

  15. P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse model

    Authors: - Journal of Clinical Investigation 2005 cited by 643

  16. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice

    Authors: , , , , , , , , , , , , , , - The FASEB Journal 2012 cited by 330

  17. Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2017 cited by 138

  18. Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2021 cited by 103

  19. Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo

    Authors: , , , , , , , , - Neuron 2008 cited by 653

  20. Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-β Peptide Catabolism

    Authors: , , , , , , , , , , , , , , - Journal of Neuroscience 2006 cited by 365

  21. Amyloid‐beta oligomerization in Alzheimer dementia versus high‐pathology controls

    Authors: , , , , , , - Annals of Neurology 2012 cited by 314

  22. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis

    Authors: , , , , , , , , , , , , - Journal of Neuroscience 2015 cited by 243

  23. Chronic Optogenetic Activation Augments Aβ Pathology in a Mouse Model of Alzheimer Disease

    Authors: , , , , , , , , , , , , , - Cell Reports 2015 cited by 232

  24. Aqp4 stop codon readthrough facilitates amyloid-β clearance from the brain

    Authors: , , , , , , , , , - Brain 2022 cited by 50